The higher affinity of SARS-CoV2 to human ACE2 compared to other corona viruses [97] and the downregulation of ACE2 in COVID-19 may explain the peculiar cardiovascular manifestations seen in vulnerable patients. Here, ACE2 is linked to COVID-19.